Please login to the form below

Not currently logged in
Email:
Password:

Rezolsta

This page shows the latest Rezolsta news and features for those working in and with pharma, biotech and healthcare.

FDA approves BMS’ Evotaz for HIV

FDA approves BMS’ Evotaz for HIV

Cobicistat is already a crucial part of several HIV treatments, including Rezolsta/Prezcobix, which pairs the drug with Janssen's Prezista (darunavir), and Gilead's own combination therapy Stribild.

Latest news

  • EMA backs 15 new medicines for use in EU EMA backs 15 new medicines for use in EU

    Janssen's HIV treatment. Janssen looks set to expand its efforts in HIV treatment with a recommendation for Rezolsta, a combination of the company's Prezista (darunavir) and Gilead's boosting

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics